The development of resistance to conventional treatment has led WHO to recommend the use of combination therapies containing aemisinin derivative (aemisinin-based combination therapies also known as ACTs). All of the following combination therapies are recommended if such resistance is suspected, except:
**Core Concept**
The development of resistance to conventional antimalarial treatment has led the World Health Organization (WHO) to recommend the use of combination therapies containing an artemisinin derivative, known as Artemisinin-Based Combination Therapies (ACTs). This approach aims to prevent the emergence of resistance and ensure effective treatment of malaria.
**Why the Correct Answer is Right**
Artemisinin-based combination therapies involve pairing an artemisinin derivative with another antimalarial drug to target different stages of the malaria parasite's life cycle. This dual-action approach helps to prevent the development of resistance and ensures effective treatment. The recommended ACTs include combinations of artemisinin with mefloquine (artemether-lumefantrine), sulfadoxine-pyrimethamine (artesunate-amodiaquine), and clindamycin (artesunate-mefloquine). The combination of artemisinin with atovaquone-proguanil (Malarone) is not recommended due to concerns about resistance.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because artesunate-mefloquine is a recommended ACT for the treatment of malaria, particularly in areas with high resistance to chloroquine and sulfadoxine-pyrimethamine.
**Option B:** This option is incorrect because artesunate-amodiaquine is a recommended ACT for the treatment of malaria, particularly in areas with high resistance to chloroquine and sulfadoxine-pyrimethamine.
**Option C:** This option is incorrect because artemether-lumefantrine is a recommended ACT for the treatment of malaria, particularly in areas with high resistance to chloroquine and sulfadoxine-pyrimethamine.
**Clinical Pearl / High-Yield Fact**
The use of ACTs has significantly improved the treatment of malaria, particularly in areas with high resistance to conventional antimalarial drugs. However, it is essential to monitor the emergence of resistance to these combination therapies and adjust treatment guidelines accordingly.
**Correct Answer:** D.